Pathogenesis of Intradermal Staphylococcal Infections: Rabbit Experimental Approach to Natural Staphylococcus aureus

Asunción Muñoz-Silvestre1, Mariola Penadés1, Laura Selva1

  • 1Biomedical Research Institute (PASAPTA-Pathology Group), Facultad de Veterinaria, Universidad Cardenal Herrera-CEU, CEU Universities, Valencia, Spain.

Insights

A new rabbit model for Staphylococcus aureus infection effectively mimics abscesses. This reproducible model is crucial for testing virulence factors and developing new treatments against this persistent pathogen.

Area of Science:

  • Microbiology
  • Immunology
  • Infectious Diseases

Background:

  • Staphylococcus aureus infections pose a significant public health challenge due to limited treatment options.
  • Existing experimental models often lack the representative nature needed to accurately assess virulence and test interventions.

Purpose of the Study:

  • To develop and characterize a novel, low-dose intradermal rabbit model for Staphylococcus aureus infection.
  • To evaluate the utility of this model in assessing bacterial virulence and host immune response.

Main Methods:

  • An experimental intradermal infection model was established in rabbits using a low dose (300 CFU) of Staphylococcus aureus.
  • Infection progression and lesion severity were monitored over 28 days.
  • Virulence mutant strains and a humanized rabbit strain (FdltB r) were inoculated to assess model sensitivity.

Main Results:

  • The low-dose intradermal model successfully reproduced characteristic staphylococcal abscesses.
  • Strains with mutations in key virulence genes showed minimal impact on lesion severity in this model, contrasting with high-dose models.
  • The humanized rabbit strain elicited an inflammatory response comparable to wild-type rabbit strains, validating its use.

Conclusions:

  • This reproducible low-dose intradermal rabbit model is a valuable tool for studying Staphylococcus aureus pathogenesis.
  • The model is suitable for evaluating both wild-type and mutant strains, aiding in the development of novel anti-staphylococcal strategies.